<DOC>
	<DOC>NCT00774722</DOC>
	<brief_summary>The purpose of this study is to determine whether metronidazole 10% ointment , applied topically three times a day in and around the anus, on the reduction of pain following haemorrhoidectomy.</brief_summary>
	<brief_title>A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy</brief_title>
	<detailed_description />
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Have Grade 3 or 4 haemorrhoids (external disease with or without significant internal component) Be scheduled for diathermy haemorroidectomy with â‰¥2 quadrant involvement Be medically fit for surgery Subjects must be aged 18 years or over and of the legal age of consent. If female, the subject must not be lactating and must be (a) postmenopausal, (b) surgically sterilised, or (c) have a negative pregnancy test result prior to entry into the study and will use adequate contraception for the duration of the study. Must have provided written informed consent to participate. They have had surgery to the anus or rectum in the past 8 weeks Suffer from a chronic pain syndrome which requires regular narcotic analgesia Have anal fissures Have diagnosed Crohn's disease Allergic to metronidazole Are taking any prohibited medication. Deemed mentally incompetent Considered by their physician unlikely to be able to comply with the protocol. Taken part in an experimental drug study in the preceding three months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>